Clinical Trial Update: Closing the Loop in Adults With Type 1 Diabetes and HbA1C<7.5% Under Free Living Conditions [NA]

View source ↗

Summary

A completed trial evaluating a closed-loop insulin delivery system in adults with type 1 diabetes under free-living conditions, targeting HbA1c below 7.5%.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: University of Cambridge | Conditions: Type 1 Diabetes | NA | Status: COMPLETED